By Y. Jack. Bowdoin College. 2018.

It has yet to be demonstrated that drugs conjugated to oligoarginines does not cause signifcant mucosal irritation due to the cationic clusters generic vantin 100mg mastercard. Once drugs are internalized into cells 200 mg vantin with visa, the overall drug absorption can be diminished by effux transporters such as large glycosylated membrane proteins generic vantin 100mg fast delivery, P-glycoproteins (P-gps), located primarily in the apical membrane of epithelial cells of the small intestine and in various other tissues throughout the body. These effux transporter systems actively pump drugs and other compounds from cells back out. The P-gp effux transporter system does not seem to select drugs by size, although most basic or uncharged drugs are more effectively transported. P-gp effux inhibitors include the drugs cyclosporin A, pluronic acid, quinidine, rifampin, and verapamil, and metabolic inhibitors ouabain and 2,4-dinitrophenol. Of special interest, pluronic acid is commonly used in a formulation of pluronic lecithin organogel to improve the skin penetration of nonsteroidal anti-infammatory agents, ibuprofen, and diclofenac acid. Substances move in and out of the brain through infux (blood-to-brain) or effux (brain-to-blood) systems. Substances move from blood to brain either by paracellu- lar or transcellular transport. In the paracellular pathway, substances leak between endothelial cells by paracellular diffusion. Very small amounts of water-soluble compounds may also traverse, on a partial or full opening of the aqueous diffusional paracellular pathway when the tight junctions are modulated. Hypoxia and the generation of reactive oxygen species, that is, oxygen radicals could open the tight junctions, resulting in an excessive penetration of white blood cells that release proteases, such as metalloproteases, to induce cytotoxic and vasogenic edema [42]. The transcellular pathway entails that substances enter the endothelial cells on the blood side and exit the cells on the brain side. Certain lipid soluble substances may pass through by transcellular passive diffusion. Saturable transport of essential polar solutes such as amines, amino acids, glucose, monocarboxylates, nucleosides, and small peptides cross by the solute carrier-mediated pathway, which may be passive or secondarily active, and unidirectional, bidirectional, or cotransport/exchanger. Viruses and essential proteins such as cytokines, insulin, leptin, and transferrin are transported through specifc receptor-mediated transcytosis. Positively charged macromolecules such as avidin, cationized albumin, and histone may nonspecifcally induce adsorptive-mediated transcytosis by electrostatic interactions with the negatively charged plasma membrane surface. This adsorptive-mediated transcytosis entry may be a reasonable explanation for the properties of cationic cell-penetrating peptides that we have previously mentioned (Section 8. We have briefy touched on the P-gp carrier-mediated effux system that pumps from the endothelial cells into blood (Section 8. Levodopa is a precursor of dopamine and is used in the management of Parkinson’s disease. A common strategy to increase brain levels of levodopa is to inhibit peripheral enzymes that either degrade levodopa or convert levodopa to dopamine in the periphery. Preventing the peripheral conversion and degradation would leave more levodopa for cerebral conversion. The L-system is selective to amino-acid-like compounds with a bulky hydrophobic side-chain [45]. Various amino acid drugs such as acivicin, phosphonoformate-tyrosine conjugates, and nitrosoarginine derivatives are also carried by the L-system. There is also a risk that the more lipophilic analog or prodrug may have a higher uptake into other tissues, that is, low target selectivity. The characteristics needed to improve peptide drug bioavailability that we have previously described in Section 8. As another thermodynamic beneft of compounds with fewer rotatable bonds, there is less fexibility in the drug [14]. Because the drug was designed to make the free conformation of the inhibitor similar to its bound conformation, there is a minimal loss of conformation entropy. Of interest, cell-penetrating Tat-peptide may also be attached to the surface of either liposomes or nanoparticles [54]. This attachment appears to greatly facilitate the internalization by cells, despite the relatively complex and large structures of the colloidal particles. With the use of cell-penetrating peptides, the per- meation of the lipophilic particles may be attributed to both adsorptive-mediated and passive diffusinal transcytosis. Hence, this emulsion system exhibits combined properties of a hydrophilic nonionic network and a swollen polyelectrolyte network. Further refnement of this system could lead to a delivery of drugs and biomacromolecules to the brain. Met-enkephalin is an endoge- nous opioid analgesic (Tyr-Gly-Gly-Phe-Met) that is prone to enzyme degradation in both brain and plasma [56]. Indeed, this improved overall bioavailability outweighs the decrease in blood-to-brain transport due to structural modifcations. We have briefy mentioned the use of markers with liposomes and nanoparticles in Section 8.

The observed numbers of cases in hospitals with universal and selective policies were compared with the numbers expected on the basis of national rates 200mg vantin visa. Separate analyses were carried out for births in hospitals that followed one policy throughout the period of study and births in hospitals in which the policy changed during the period of study discount vantin 200 mg with visa. The ratio tended to be smaller in hospitals with a selective policy than in those offering universal prophylaxis buy 100 mg vantin otc. Studies of Cancer in Experimental Animals No reports of studies specifically designed to investigate the carcinogenicity of vitamin K substances were available to the Working Group. One study on the initiating effects of menadione in an assay of liver foci in rats was available (Denda et al. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms The studies summarized in this section should be considered in the light of the differences between naturally occurring forms of vitamin K that have a lipophilic side- chain at the 3-position of the 2-methyl-1,4-naphthoquinone (menadione) ring structure (phylloquinone and menaquinones) and the synthetic forms which lack this side-chain (menadione and its water-soluble derivatives). Lack of this side-chain results in profound differences in the absorption, tissue distribution and metabolism of natural K vitamins. In the strict sense, menadione is a provitamin K, because it is biologically active for the synthesis of vitamin K-dependent proteins only after conversion to the naturally occurring menaquinone-4 (four prenyl units) in vivo. It is absorbed chemically unchanged from the proximal intestine after solubilization into mixed micelles composed of bile salts and the products of pancreatic lipolysis. In healthy adults, the efficiency of absorption of phylloquinone in its free form is about 80% (Shearer et al. Within the intestinal mucosa, phylloquinone is incorporated into chylomicrons, is secreted into the lymph and enters the blood via the lacteals (Shearer et al. After a phylloquinone-containing meal, the plasma concentration peaks between 3 and 6 h (Shearer et al. Once in the circulation, phylloquinone is rapidly cleared at a rate consistent with its continuing association with chylomicrons and the chylomicron remnants that are produced by lipoprotein lipase hydrolysis at the surface of capillary endothelial cells. During the postprandial phase and after an overnight fast, more than half of the circulating phylloquinone is asso- ciated with triglyceride-rich lipoproteins, and the remainder is carried by low-density and high-density lipoproteins (Kohlmeier et al. Although phylloquinone is the major circulating form of vitamin K, menaquinone-7 is present in plasma at lower concentrations and has a similar lipoprotein distribution to phylloquinone. While phylloquinone in blood is derived exclusively from the diet, it is not known what proportion of circulating menaquinones such as menaquinone-7 derives from the diet or the intestinal flora (Shearer et al. A gradual slowing of the clearance rate was seen after the first 6 h (Shearer et al. This slowing of the clearance rate may be explained by the complexity of the plasma transport of phylloquinone, in which the proportion of phylloquinone associated with low-density and high-density lipo- proteins increases progressively (Lamon-Fava et al. The plasma disposition of oral doses of 5–60 mg phylloquinone (Konakion or AquaMephyton) is similar to that found after a more physiological dose (≤ 1 mg), with peak plasma concentrations at 4–6 h followed by a rapid clearance phase (Shearer et al. After an oral dose of 10 or 50 mg Konakion, the plasma concentration declined from the peak absorptive level at a similar log-linear rate as that seen after intravenous adminis- tration, with a terminal half-time of about 2 h for measurements up to 9–12 h (Park et al. The absorption of oral preparations of phylloquinone shows inter- and intra-individual variation and, for doses of Konakion ranging from 10 to 60 mg, the bioavailability was 10–63% (Park et al. The pharmacokinetics of phylloquinone after an intramuscular dose is completely different, showing sustained, slow release from the muscle site over many hours and marked inter-individual variation (Hagstrom et al. After intramuscular injection of phylloquinone (AquaMephyton R), most of the substance was carried by low-density and high- density lipoproteins instead of by triglyceride-rich (very-low-density) lipoproteins as found after oral administration (Hagstrom et al. An early study of the plasma disposition of 1 mg Konakion given orally or intra- muscularly at birth showed wide inter-individual differences during the first 24 h, especially after oral administration (McNinch et al. The peak plasma concen- tration after an oral dose occurred after 4 h; the median concentration was 73 ng/mL, which fell to 23 ng/mL after 24 h. The plasma concentration after administration of 1 mg of Konakion intramuscularly exceeded those after oral administration at all times, and after 24 h the median was 444 ng/mL. Physiologically, these concentrations compare with adult endogenous levels of about 0. By 24 days, the concentrations in both groups were mainly within the adult physiological range (0. In this study, however, the plasma concentrations after 24 days were significantly higher after intramuscular injection, consistent with the hypothesis of the depot effect of intramuscular phyllo- quinone (Loughnan & McDougall, 1996; see also section 4. They calculated from published studies that a realistic estimate of the terminal plasma half-time in neonates was 26–193 h (median, 76 h), as compared with 8–22 h (median, 14 h) in adults after intravenous administration (Øie et al. This longer terminal half- time may reflect the poorly developed organ systems of neonates and a reduced capacity to metabolize and excrete vitamin K (Stoeckel et al. The plasma profile of an oral dose of this preparation in five-day- old infants appeared to be similar to that of phylloquinone; after a 4-mg dose, a peak concentration of about 100 ng/mL was achieved after 3–4 h, before declining to about 30 ng/mL by 12 h (Shinzawa et al. The liver has often been assumed to be a major depot for vitamin K because it is the site of synthesis of the vitamin K-dependent coagulation proteins.

Each of the in- multiply the percent so found by the gredients used in the food shall be de- weight of such fruit juice ingredient; clared on the label as required by the (iii) divide the result by 100; (iv) sub- applicable sections of parts 101 and 130 tract from the quotient the weight of of this chapter cheap vantin 200 mg with visa, except that: any added saccharine ingredient solids (i) The name(s) of the fruit or fruits or other added solids; and (v) multiply used may be declared without speci- the remainder by the factor for such fying the particular form of the fruit or fruit juice ingredient prescribed in fruits used order vantin 200 mg with amex. The re- (ii) When the optional ingredients sult is the weight of the fruit juice in- listed in paragraphs (c) (3) vantin 100mg discount, (4), and (5) gredient. The quantity of the fruit carrageenan standardized with nutri- juice ingredient, calculated as set out tive sweetener, no nutritive sweetening in §150. The article is sealed in containers used to make artificially sweetened and so processed by heat, either before fruit jelly. Pectin may be standard- (4) Sodium hexametaphosphate in an ized with a nutritive sweetening ingre- amount not exceeding 8 ounces avoir- dient, but such sweetening ingredient dupois per 100 pounds of the finished shall not amount to more than 44 per- food. The words "artificially sweet- gredients complying with the require- ened" shall be prominently and con- ments of §150. I (4–1–10 Edition) smaller than the largest letter used in viscous or semi-solid foods, each of any other word in the name of the food. Such mix- this section is used, the label shall bear ture, with or without added water, is the statement "lll added" or "with concentrated with or without heat. The added lll", the blank being filled in volatile flavoring material from such with the words "spice", "spice oil", or mixture may be captured during con- "spice extract" as appropriate, but in centration, separately concentrated, lieu of the word "spice" in such state- and added back to any such mixture, ment the common name of the spice together with any concentrated es- may be used. Each of the in- weight of each is not less than one-fifth gredients used in the food shall be de- of the weight of the combination; ex- clared on the label as required by the cept that the weight of pineapple may applicable sections of parts 101 and 130 be not less than one-tenth of the of this chapter. In any combination of two, three, four, (iv) In the case of concentrated fruit, or five fruits, each such fruit is an op- the weight of the properly prepared tional ingredient. For the purposes of fresh fruit used to produce such con- this section the word "fruit" includes centrated fruit. I fruit or a permitted combination ex- (4) The weight of any optional sac- clusively of Group I fruits, 47 parts by charine ingredient means the weight of weight of the fruit ingredient to each the solids of such ingredient. The weight of the method prescribed in "Official Methods fruit ingredient shall be determined in of Analysis of the Association of Offi- accordance with paragraph (d)(2) of cial Analytical Chemists," 13th Ed. I (4–1–10 Edition) (i) If the fruit ingredient is a single Such food may also contain one or fruit, the name is "Preserve" or more of the following optional ingredi- "Jam", preceded or followed by the ents: name or synonym whereby such fruit is (1) Spice, spice oil, spice extract. Each of the in- trate, or any combination thereof, in gredients used in the food shall be de- an amount not exceeding 2 ounces av- clared on the label as required by the oirdupois per 100 pounds of the finished applicable sections of parts 101 and 130 food. Except as para- graph (c) of this section, and with or graph (d) of this section permits the without water and a jelling ingredient use of pectin, carrageenan, or salts of as specified in paragraph (d) of this sec- carrageenan standardized with nutri- tion. The quantity of the fruit ingre- tive sweetener, no nutritive sweetening dient amounts to not less than 55 per- ingredient is added, either directly or cent by weight of the finished food. The indirectly, to the fruit ingredient used article is sealed in containers and so to make artificially sweetened fruit processed by heat, either before or preserves or artificially sweetened after sealing, as to prevent spoilage. Pectin may be standard- ized with a nutritive sweetening ingre- used, the label shall bear the statement dient, but such sweetening ingredient "lll added as a preservative", the shall not amount to more than 44 per- blank being filled in with the common cent by weight of the standardized pec- name by which the preservative ingre- tin and the quantity of such standard- dient used is designated in paragraph ized pectin used shall not exceed 3 per- (a)(6) of this section. Each of the in- scribed by this section consists of the gredients used in the food shall be de- words "artificially sweetened" imme- clared on the label as required by the diately followed by the name pre- applicable sections of parts 101 and 130 scribed by §150. I (4–1–10 Edition) Subpart B—Requirements for (i) The fruit content of the pie is such Specific Standardized Fruit Pies that the weight of the washed and drained cherry content is not less than §152. The top of coloration, scar tissue, or other abnor- the pie may be open or it may be whol- mality. A cherry showing skin discol- ly or partly covered with pastry or oration (other than scald) having an other suitable topping. Filling, pastry, aggregate area exceeding that of a cir- and topping components of the food cle nine thirty-seconds of an inch in di- consist of optional ingredients as pre- ameter is considered to be blemished. The at 70°–75 °F to free the cherries and word "frozen" may be omitted from cherry fragments from the adhering the name on the label if such omission material. Such alternative statement shall deemed in compliance for the following immediately and conspicuously pre- factors, to be determined by the sam- cede or follow, without intervening pling and acceptance procedure as pro- written, printed, or graphic matter, the vided in paragraph (c) of this section, name of the food as prescribed by para- namely: graph (a) of this section. A lot shall be deemed to be in compliance for fill of Subpart A—General Provisions container (packing medium and vege- Sec. A lot shall be Standardized Canned Vegetables deemed to be in compliance for drained weight based on the average value of 155. A container, a por- of equal diameter, or the color equiva- tion of the contents of a container, or lent of such discs: a composite mixture of product from Disc 1—Red (5R 2. For fill of container, the sample Disc 4—Grey (N4) (mat finish) unit shall be the entire contents of the container. Any sample unit shall diffused daylight or under a diffused be regarded as defective when the sam- light source of approximately 2691 lux ple unit does not meet the criteria set (250 footcandles) and having a spectral forth in the standards. The max- under a moderately overcast sky, with imum number of defective sample units a correlated color temperature of 7,500 permitted in the sample in order to degrees Kelvin ±200 degrees.

The assay of Na buy vantin 200 mg cheap, K and Ca in blood serum and water; assay of Ba buy vantin 200mg without a prescription, K and Na in calcium lactate have been described followed by cognate assays vantin 100 mg with visa. Part—V is solely confined to the ‘Assay Methods based on Separation Techniques’ and is spread over five chapters. Liquid-liquid extraction (Chapter 27) mostly treats the subject theoretically and is supported by appropriate examples. Errors due to the volume change and effectiveness of an extraction have been dealt with adequately. Various factors that influence solvent extraction, such as : temperature and inert solutes, pH ion-pair formation and synergistic extraction have been described. Size Exclusion Chromatography (Chapter 31) has also been included as a means of analysis for substances that undergo separation more or less as per their molecular size, viz. It is earnestly believed that ‘Pharmaceutical Drug Analysis’ will fulfill the entire requirements of both penultimate and final year students of B. It may also help the post-graduate students in their compulsory paper on ‘Modern Analytical Techniques’ to a great extent. Academicians and researchers engaged in the evaluation of pharmaceutical drug substances either in pure or dosage forms will also enormously benefit from ‘Pharmaceutical Drug Analysis’ by virtue of its ultimate goal of maintaining very high standards of quantitative analysis. Finally, I wish to record here my special thanks to the numerous colleagues and friends who have not only extended their invaluable help by providing me with relevant sources of material but also by taking an active participation in the discussion of various chapters. It is hoped that ‘Pharmaceutical Drug Analysis’ will soon prove to be an invaluable guide to both undergraduate and postgraduate students and to my esteemed colleagues in the teaching profession. Those working in Research & Development Laboratories, Quality Assurance Laboratories and Drug Testing laboratories will also find the book helpful in solving many of their intricate problems. Applications of Karl Fischer Method for Determination of Water in Pharmaceutical Analysis............................................................................................... Amperometric Titrations with Twin-Polarized Microelectrodes (Biamperometric Titrations or Dead-Stop-End-Point Method).................... To Distinguish and Characterize the pri-, sec- and tert-amine Salts from One Another............................................................................................ Determination of Specific Organic Compounds as Impurities in Official Pharmaceutical Substances............................................................... Medicinal chemists, pharmacologists, biochemists, analytical chemists and medical professionals have paved the way with their single goal objective to combat the sufferings of human beings. In this integrated effort the role of an analyst vis-a-vis the chemical purity of pharmaceutical substances and drugs made therefrom and finally the dosage forms that are usually available for direct patient’s usage, has become not only extremely crucial but also equally important and vital. As on date product safety has to be an integral part of all product research in pharmaceutical substances. Inspite of all the qualified successes of synthetic drug research achieved in the last four decades to combat infectious diseases of the more than 80,000 different ailments, unfortunately only about one third can be treated with drugs, most of them only symptomatically. In order to meet these challenges one needs to adopt novel approaches in pharmaceutical research. Both molecular biology and genetic engineering will be exploited duly in opening up new routes. It is, however, pertinent to mention here that pharmaceutical chemicals must maintain a very high degree of chemical purity. It is quite obvious that a state of absolute purity may not be achievable, but a sincere effort must be exercised to obtain the maximum freedom from foreign substances. Bearing in mind the exorbitant operational costs to attain the ‘highest standards’ of purity, perhaps some of these processes are not economically viable. Therefore, a compromise has got to be made to strike a balance between the purity of a substance at a reasonably viable cost and at the same time its purity e. In short, a host of impurities in pharmaceutical chemicals do occur that may be partially responsible for toxicity, chemical interference and general instability. In this chapter, the purity and management of pharmaceutical chemicals, would be discussed briefly so as to take adequate cognizance of the importance of standardization of these substances, in addition to their management by Official Methods. The standards for pharmaceutical chemicals and their respective dosage forms, as laid down in, various Official Compendia fulfil broadly the following three cardinal objectives, namely : (a) Broad-based highest attainable standard, (b) Biological response versus chemical purity, and (c) Offical standards versus manufacturing standards. A wide variation of active ingredients ranging between 90% in one sample and 110% (± 10 per cent limit) in another sample could invariably be observed. Therefore, it has become absolutely essential to lay down definite standards so as to ensure that : • Different laboratories may produce reasonably reproducible products. Examples : (i) Substances to be stored in well-closed, light-resistant containers e. It is a well-known fact that a pharmaceutical substance can be prepared by adopting different routes of synthesis based upon the dynamic ongoing research in the field of organic-reaction-mechanisms.